National Surgical Adjuvant Breast and Bowel Project (NSABP)
AC Chemotherapy Regimen (Doxorubicin + Cyclophosphamide) - PDF Free Download
Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study - ScienceDirect
Effect of Number of Treatment Cycles of Adjuvant Chemotherapy on Clinical Outcomes | Research To Practice
Clatterbridge Centre for Oncology Chemotherapy Protocols
1607-Breast adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense followed by PACLitaxel dose de | eviQ
4102-Breast adjuvant/neoadjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense | eviQ
Carboplatin for Patients With Triple-Negative Breast Cancer
Pregnancy-Associated Breast Cancer
AC Regimen [Doxorubicin, Cyclophosphamide]
Cancers | Free Full-Text | Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
Chemotherapy protocol definition form | Download Scientific Diagram
Schema. T, Taxotere (docetaxel); AC, doxorubicin/cyclophosphamide. | Download Scientific Diagram
Current Oncology | Free Full-Text | Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program
Chemotherapy regimens for breast cancer. | Download Table
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial - The Lancet
Breast Cancer Update .com - Web Guide 1 2003
JCM | Free Full-Text | Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
Chemotherapy protocol a for HR ALL patients | Download Table
National Surgical Adjuvant Breast and Bowel Project (NSABP)
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C | British Journal of Cancer
AC-PACLitaxel Treatment
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel... | Download Table
PDF) Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel (Dose Dense AC Followed by T) Regimen for Breast Cancer
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial - The Lancet Oncology
